In this case study, the Low Intensity Laser was used in the oral cavity (tongue and salivary glands) 
Introduction
Dysgeusia is variably defined as an abnormality detrimental to taste sensations that causes unpleasant palate alteration, or a distortion or perversion of the sense of taste. It is closely linked to changes in taste and smell as they provide sensory information correlated with sensory pleasure that are directly affected by cancer-related therapies [1] .
These changes in taste and smell in cancer patients are prevalent problems due to therapeutic interventions that affect quality of life, leading to malnutrition, weight loss and, in severe cases, significant morbidity [2] . Dysgeusia is assessed clinically by measuring the detection or recognition threshold values for the five sub-gustations ( Figure 1 ): sweet, bitter, acid, salty and umami (the taste of protein-rich foods), whether by the application of filters (paper taste strips impregnated with various concentrations of basic taste) or, in the laboratory environment, with the use of an instrument called elegance.
In fact, these qualitative changes are more reliable when reported through patient complaints, interviews and clinical observations [3] . This sensory system in cancer patients is orchestrated by numerous exogenous and endogenous factors that interact with one another. Faced with this, these factors are responsible for taste and odor abnormalities due to this interconnection. However, this damage to sensory receptor cells is abnormal, but the etiology of these is related to the neuronal activities causing the abnormalities of taste and odor in these patients.
And according to scientific research, these disorders are probably multifactorial, although it is conclusive by many authors that chemotherapy and radiotherapy can cause disruption to taste in the destruction of olfactory and taste cell receptors. And this cellular damage may manifest in three ways: (a) a decrease in the number of normal recipient cells, (b) structural cell alteration or changes in the receptor surface, and (c) disruption in neural coding. Photobiomodulation (PBM) is a non-invasive infrared and red-light therapy that is absorbed by endogenous chromophores, triggering biological reactions that are not thermal or cytotoxic by means of photochemical or photophysical events, leading to physiological changes. Radiation emitted at certain wavelengths can modulate cells and bring physiological balance to tissues [4] .
Medical Case Reports Journal
Photobiomodulation is known as low intensity laser therapy because the light used is low power compared to other forms of laser health treatments, which are used in other areas of medicine, such as surgery [4] . In recent studies it has been reported that the mechanism of action of PBM is closely related to an action on cytochrome c oxidase (CcO) in the mitochondrial respiratory chain, facilitating the electron transport that promotes an increased transmembrane proton gradient, stimulating the production of triphosphate of adenosine (ATP), increasing the functions of cellular metabolism [5, 6] .
Low intensity laser therapy improves tissue regeneration by acting at different stages of lesion resolution, including the inflammation and re-modeling phases [7] . Some beneficial effects such as immunosuppression-immunostimulation, autoimmune disease and nerve regeneration have been reported in the literature. It is gaining recognition as a viable treatment option for a diverse range of diseases and conditions characterized by injury, degeneration, inflammation and pain [8] . "The laser was not able to replace many of today's techniques and physical modalities; however, it can be used together to improve the health of patients [9] ." On the other hand, the complementary function, Ilib, triggers an antioxidant system composed by enzymes. The main metallo enzyme superoxide dismutase, or SOD ZnCu, is the largest antioxidant agent [10] that we have and fifth volume enzyme in the human body. However, according to a recent review, evidence suggests that the enzymes catalaseperoxidase and ceruloplasmin also absorb the red laser which potentiates other enzymes, which obviously further potentiates the antioxidant properties of these enzymes when irradiated in the ILIB process.
Case Report
A 63-year-old white female RQS diagnosed with multifocal invasive right breast carcinoma in May 2017. Tumorectomy and lymphadenectomy of axillary lymph nodes were performed in June 2017, followed by treatment with chemotherapy (QT) 4 cycles (docetaxel), ending in January 2018. Patient used oral dexamethasone, with clinical status of G1 mucositis, hyporexia, G2 diarrhoea, G1 myalgia, skin lesions and tearing. In October of 2017, during Q3 C3, he presented to the Dentistry Service of the Hospital do Cancer for diagnosis and follow-up of reflexes from oncological therapies. In the initial consultation, the use of a provisional superior prothesis (5 implants) and lower teeth under normal conditions was observed, but the patient's main complaint was the loss of the palate function, called dysgeusia (Figure 2) , which made the diet difficult habitual. It reported that the sensory function of the tongue had been compromised which affected the perceptions of salt and sweet flavors. Upon confirmation of the sensorial alteration of the tongue, initial topical therapy with the use of 3X mouthwashes per day of chamomile tea at room temperature [11] was proposed; advice on diet in order to avoid acidic and peptic foods; photobiomodulation (low intensity laser therapy) in the oral cavity; and photoenteral via ILIBIntravascular Irradiation off blood [12] . The main objective of this study was to perform controlled phototherapy in the lingual region and the major salivary glands (parotid, submandibular, sublingual), non-invasive in this patient of the Cancer Hospital of Ribeirão Preto (SP), through the EC laser, DMC brand, useful red laser emitter: 100 mW ± 20%, red laser wavelength 660 nm ± 10 nm, photobiomodulator effect, with specific protocol, and use of the photothermal/Ilib (Intravascular Laser Irradiation of blood) function in the radial artery of the wrist as a complementary action.
Clinical conduct (Protocol¹)
• Before each session, the patient's initial blood pressure was evaluated.
• Hygiene of the oral cavity with clodiaxidine 0.12% by digital friction, using the sterile gauze.
• Perception of taste flavors through manual technique.
• Application of the Low Intensity Laser (LIB) laser XT, DMC brand, useful red emitter laser power: 100 mW ± 20%, red laser wavelength 660 nm ± 10 nm, 1joule (10 seconds)-red 10 seconds in bilateral salivary glands (parotid, sublingual and submandibular), and in the lingual region (lateral border 9 points 1 joule/point and 2 joules on the back).
• Complementary 15-minute photoenteral therapy (Ilib) in the radial artery of the wrist.
• Checking the final blood pressure.
• The sensory measurement of the taste buds was materialized by personalized scale of the Hospital of Cancer of Ribeirão Preto, being marked by small doses (0.25 grams) of the flavors related to salt, sweet, sour and bitter: Scale proposed in Table 1 (Palate reduced 1; sharp palate; 2; normal taste 3) The patient was followed weekly (2 times / week) for 2 months on alternate days for the application of Lib (Figure 3a) , and simultaneously with Ilib therapy (Figure 3b ) according to the indoctrination proposed by co-author² on "patient management "Who need greater regulatory control of general health status. The results obtained were increasing until reaching the normalization of the sensory function before the proposed period initially, according to Table 1 below: 
Discussion
In this study, the initial proposal was to promote a noninvasive dosing through local and systemic photobiomodulation aiming at the partial or total reestablishment of the sensory dysfunction of the patient. The results obtained after the first application of the laser (lib and ilib) demonstrated after 3 days the recovery of the palate, previously numbed by oncological therapies. There was an increase in flavors (mainly related to sweet and salty) that positively impacted the enteral quality of life of the same, even relativizing the lack of balance of the taste buds in the extremism of the tastes.
This accentuation produced a better latency of oncoterapic medications, higher results of laboratory markers and a fundamental impact on self-esteem, which allowed a better resumption of quality of life. Chemotherapy has a severity of dysgeusia by altering the structure of the pores of the taste (resulting in the interrupted delivery of flavor molecules to the recipient cells) or causing a thinning of the papilla epithelium [13] . Cancer treatment can also affect neuronal activities as well as receptor cells. In addition, antineoplastic drugs can damage neuronal cells, thereby modifying the afferent pathways that trigger the taste. Recent research has indicated that lipid peroxidation of oral epithelial cells may contribute to the production of carbonyls that cause a metallic taste sensation. Bitter and metallic sensations may also originate from the toxicity of chemotherapeutic drugs.
Many of these drugs have bitter-tasting compounds that can enter the mouth through the plasma crevicular fluid or may diffuse capillaries to the back of the palate. Drugs that are not anti-neoplastic agents, including antibiotics and analgesics (which are often taken by cancer patients to minimize side effects) may also influence taste perception. And other possible causes of unpleasant taste changes that these patients may present, formerly produced by poor oral hygiene, infection, postnasal drip, gastrointestinal reflux and oral mucositis [14] may be highlighted. Currently, the Low Intensity Laser (LBI) is being used for the global recovery of the patient in several specialties of the health area; and their responses are considered beneficial [15, 16] in a variety of different modalities, due to their photobiomodulatory effect [17] .
Specifically, this mechanism when triggered in the craniofacial region is related to "neural repair and neurogenesis "Not only in the formation of new brain cells, but also in" synaptogenesis", which is the formation of new connections between existing brain cells [18] . Therefore, it should be noted that the systemic and localized conditions during cancer treatment therapy contribute to the reduction of the sensory capacity of the palate, causing transient or definitive dysgeusias, and in this niche of patients who use chemotherapeutic drugs these functions are altered often with a negative influence on the organic and emotional well-being of these people.
When it acts at the cellular level, the low power laser causes biochemical, bioelectric and bioenergetic modifications, influencing the increase of metabolism, cell proliferation and maturation, the amount of granulation tissue and the decrease of the inflammatory mediators, inducing the process of healing [19] . This radiation emitted by the Low Power Lasers has demonstrated analgesic, anti-inflammatory and healing effects and is therefore widely used in the tissue repair process, due to the low energy densities used and wavelengths capable of penetrating the tissues [20, 21] . And when the molecule is absorbed by light allows an increase in cellular metabolism, characterized by stimulation of photoreceptors in the mitochondrial [22, 23] .
And in this study the patient returned to perform the normal and nutritional tasks with a certain success after the 1 st application and the evolution became a growing in the next 13 consultations until arriving at the normalization in the 14 th and consequent stabilization of the picture. The dysgeusia called dysgeusia, began as Ageusia (absence of flavor), evolved to Hypogeusia (low perception of the flavors), then to a Hypergeusia (high taste sensitivity), getting to oscillate between the flavors (Dysgeusia) until the normalization of sensory function of the tongue (Figure 4 ). 
Conclusion
The clinical evolution of this specific case is undeniable through photobiomodulation, and it is important the multidisciplinary involvement of all the staff in their various specialties that contributed in an assertive way to stabilize the picture. Although the clinical results look very promising, and the low-power laser fits perfectly into the realm of technological therapy, care must be taken not to regard it as a new panacea. The ideal that this technology continues to perpetuate advances in the oral cavity, from which the systemic repercussions potentiate benefits radiated to other sites fundamental to the maintenance of health.
